La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Antiparkinson Agents (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiparkinson Agents (administration & dosage) < Antiparkinson Agents (adverse effects) < Antiparkinson Agents (chemistry)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 132.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000199 (2000) Pergolide and Parkinson's disease: new preparation. No clear benefit.
000200 (2001) O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Yves Agid [France]Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
000202 (2001) E. Bezard [France] ; J M Brotchie ; C E GrossPathophysiology of levodopa-induced dyskinesia: potential for new therapies.
000226 (2002) M L Welter [France] ; J L Houeto ; S. Tezenas Du Montcel ; V. Mesnage ; A M Bonnet ; B. Pillon ; I. Arnulf ; B. Pidoux ; D. Dormont ; P. Cornu ; Yves Agid [France]Clinical predictive factors of subthalamic stimulation in Parkinson's disease.
000239 (2002) Paul Krack [France] ; Valérie Fraix ; Alexandre Mendes ; Alim-Louis Benabid ; Pierre PollakPostoperative management of subthalamic nucleus stimulation for Parkinson's disease.
000244 (2002) Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
000248 (2002) I. Ghorayeb ; F. Yekhlef ; V. Chrysostome ; E. Balestre ; B. Bioulac ; F. TisonSleep disorders and their determinants in multiple system atrophy
000252 (2002) P. Krystkowiak [France] ; L. Defebvre[Rush dyskinesia scale or Goetz scale].
000270 (2002) Selegiline: a second look. Six years later: too risky in Parkinson's disease.
000274 (2002) O. Rascol [France] ; P. Payoux ; J. Ferreira ; C. Brefel-CourbonThe management of patients with early Parkinson's disease.
000283 (2002) Elena Moro [France] ; Rianne J A. Esselink ; Alim Louis Benabid ; Pierre PollakResponse to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation.
000301 (2002) E. Lagrange [France] ; P. Krack ; E. Moro ; C. Ardouin ; N. Van Blercom ; S. Chabardes ; A L Benabid ; P. PollakBilateral subthalamic nucleus stimulation improves health-related quality of life in PD.
000316 (2003) Olivier Rascol ; Pierre Payoux ; Fabienne Ory ; Joaquim J. Ferreira ; Christine Brefel-Courbon ; Jean-Louis MontastrucLimitations of current Parkinson's disease therapy.
000320 (2003) Marc Ziegler [France] ; Alexandre Castro-Caldas ; Susanna Del Signore ; Olivier RascolEfficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study.
000323 (2002) O. Rascol [France] ; J J Ferreira ; P. Payoux ; Ch Brefel-Courbon ; J L Montastruc[Management of levodopa-induced dyskinesia].
000347 (2003) Olivier Rascol [France]Monoamine oxidase inhibitors--is it time to up the TEMPO?
000355 (2003) Sylvie Raoul [France] ; Mirella Faighel ; Isabelle Rivier ; Marc Vérin ; Youenn Lajat ; Philippe DamierStaged lesions through implanted deep brain stimulating electrodes: a new surgical procedure for treating tremor or dyskinesias.
000359 (2003) Julie Hudry [France] ; Stéphane Thobois ; Emmanuel Broussolle ; Patrice Adeleine ; Jean-Pierre RoyetEvidence for deficiencies in perceptual and semantic olfactory processes in Parkinson's disease.
000362 (2003) Yassine Darbaky [France] ; Claude Forni ; Marianne Amalric ; Christelle BaunezHigh frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task.
000366 (2003) Entacapone/levodopa/carbidopa combination tablet: Stalevo.
000404 (2003) Bechir Jarraya [France] ; Anne-Marie Bonnet ; Charles Duyckaerts ; Jean-Luc Houeto ; Philippe Cornu ; Jean-Jacques Hauw ; Yves Agid [France]Parkinson's disease, subthalamic stimulation, and selection of candidates: a pathological study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (adverse effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiparkinson Agents (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (adverse effects)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024